FilingReader Intelligence
Chugai to build 80bn yen lab, reports solid H1 results
July 24, 2025 at 07:10 AM UTC•By FilingReader AI
Chugai Pharmaceutical will construct a new laboratory in Tokyo for 80 billion yen, with construction starting May 2026 and completion by August 2028.
The company reported H1 2025 revenue of 578.5 billion yen, up 4.6% year-on-year, and operating profit of 273.3 billion yen, up 5.8%.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
CONSOLIDATED FINANCIAL STATEMENTS (IFRS) (Non-Audited) (for the six months ended June 30, 2025)July 24, 2025 at 07:00 AM UTC
Chugai to Construct a New Laboratory Building "UKX" to Strengthen Manufacturing Process Development Capabilities and Advance Environmental InitiativesJuly 24, 2025 at 07:00 AM UTC
A decision has been made to construct a new research building (UKX) to strengthen pharmaceutical manufacturing process development capabilities and promote environmental measures towards achieving TOP I 2030.July 24, 2025 at 07:00 AM UTC
TSE:4519•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Chugai Pharmaceutical publishes news
Free account required • Unsubscribe anytime